Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000446 · ClinicalTrials.gov registry record · Phase 2
Drug Treatment for Alcoholics With Post-Traumatic Stress Disorder
A Phase 2 study, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- Completed
- Registry status
- Phase 2
- Development phase
NCT00000446 is a Phase 2 study that has completed, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
The verdict
NCT00000446, a Phase 2 study, has completed, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
This study will investigate the use of sertraline (Zoloft) to decrease alcohol consumption and crime-related post-traumatic stress disorder in those individuals with both disorders. This will be a 12-week, placebo-controlled, double-blind outpatient trial. All subjects will receive cognitive behavioral therapy in addition to a placebo or sertraline. Comprehensive evaluation will be done at study entry; treatment termination; and 6, 9, and 12 months after study entry.
Interventions
- DRUG sertraline (Zoloft)
Trial Details
| Field | Value |
|---|---|
| Est. Completion | 2000-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000446
The ClinicalTrials.gov registry entry for NCT00000446 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which sertraline (Zoloft) is the first listed.
NCT00000446 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000446 about?
NCT00000446 is a clinical study titled "Drug Treatment for Alcoholics With Post-Traumatic Stress Disorder". This study will investigate the use of sertraline (Zoloft) to decrease alcohol consumption and crime-related post-traumatic stress disorder in those individuals with both disorders. This will be a 12-week, placebo-controlled, double-blind outpatient trial. All subjects will receive cognitive behavi...
What is the current status of trial NCT00000446?
This trial is currently completed. It is a Phase 2 study. Estimated completion is 2000-12.
What interventions are being tested in trial NCT00000446?
The interventions under investigation include: sertraline (Zoloft) (DRUG).
Who is sponsoring clinical trial NCT00000446?
This trial is sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.